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Abstract 
Extracellular vesicles (EVs) are released by nearly all cell types within the human 
body and have been found to play important biological roles including cell-to-cell 
communication, apoptosis and tissue repair. Lacking cellular machinery, these nano-sized 
vesicles carry functional proteins and nucleic acids from their parent cells, providing insight 
into biomarkers present in healthy, cancerous and diseased cells. EVs may be isolated from 
biofluids such as from blood or urine. Their detection and characterization holds extreme 
potential in developing less invasive disease detection and treatment methods. 
In this work, we propose use of lithographic techniques to fabricate platforms to 
allow for molecular-level characterization by surface-enhanced Raman spectra (SERS). Two 
methods of lithography are proposed to probe spectral signatures of individual EVs without 
use of labelling agents. SERS spectra are acquired for EVs released from two cell lines, 
allowing for determination of the diversity existent within a cell line, and amongst different 
cell lines.  
Keywords 
4-mercaptophenyl boronic acid (4-MPBA), biosensing, electron beam lithography (EBL), 
exosome, extracellular vesicle (EV), localized surface plasmon resonance (LSPR), 
nanosphere lithography (NSL), Raman spectroscopy, surface enhanced Raman spectroscopy 
(SERS). 
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Chapter 1  
1 General Introduction 
The development of nanomaterials and their integration using micro- and 
nanoscale fabrication has driven a rapid increase in development of point-of-care 
technologies in recent decades.1-4 These applications have yielded a variety of sensing 
devices with extreme sensitivity, and have been applied to study a variety of biological, 
physical and chemical phenomena with sensing capabilities down to the single molecule 
level.5 This thesis seeks to develop and characterize a sensing platform to trap and detect 
nanoscale biological materials known as extracellular vesicles. Exosomes and 
microvesicles, two categories of extracellular vesicles range in size between 100 nm to 1 
micron and are the subjects of very active field of research due to their chemical stability 
and relation to disease detection and diagnostics. We propose the use of an advanced 
spectroscopic method with high sensitivity and specificity, known as surface-enhanced 
Raman spectroscopy to detect and characterize individual extracellular vesicles.  
1.1 Overview 
Raman spectroscopy has emerged as a powerful optical technique for studying 
biological materials such as cells,6 proteins7 and nucleic acids.8, 9 Upon irradiation with 
an intense light source, matter will scatter light either elastically (exhibiting no change of 
energy), known as Rayleigh scattering, or inelastically known as Raman scattering. 
Raman scattering involves a change of energy either towards higher energies (anti-Stokes 
Raman scattering) or smaller energies (Stokes scattering).10 The energy changes 
associated with the Raman scattering contain information pertaining to the vibrational 
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modes of molecules. Inelastic scattering was first reported in the literature in 1928 by 
C.V Raman upon questioning the characteristic blue color of water.11 This discovery led 
to the birth of a new field, and subsequently to a Nobel Prize awarded to C. V. Raman in 
1930. Although Raman spectroscopy became a new tool in the scientist’s toolkit 
following its initial discovery, developments within the field were limited for many years 
due to the relative weakness of Raman scattering without availability of intense 
monochromatic light sources or highly sensitive detectors. The development of lasers, 
charge coupled devices (CCD), and the combination of Raman measurements with 
optical microscopy have all led to further development of modern Raman instrumentation 
that provides spectra with exquisite sensitivity and spatial resolution. The applications 
range across many fields such as study of semiconductor materials,12, 13 physical 
materials14 and biological samples.9 
Further to the general principle of Raman spectroscopy, in 1974, Fleischmann et 
al. observed a Raman signal one million times stronger than hypothesized when 
obtaining the Raman spectra of pyridine molecules adsorbed to a roughened metal 
electrode surface.15 This discovery lead to the concept of surface-enhanced Raman 
spectroscopy (SERS). Following Fleischmann’s serendipitous discovery, the physical 
principles responsible the SERS enhancement became a field of great interest. In 1977, 
Creighton16 and Van Duyne17 proposed the electromagnetic and chemical enhancement 
mechanisms for the SERS enhancement that is observed only in conductive surfaces such 
as rough metals or other nanostructured conductive materials. Since then, scientists have 
probed information on chemical identity,18 composition,18 structure,19 purity20 and 
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symmetry21 using SERS, which has now become a well used methodology for research 
across a variety of scientific subdisciplines.  
With SERS, Raman scattering is typically enhanced by a factor of 102 – 109 
enabling the detection of the analytes positioned near a metallic nanostructured surface 
with weak laser intensity and/or short acquisition time.22 The large enhancement enabled 
by SERS is sufficient to allow for single molecule detection making it a valuable 
technique for biomedical applications.23 The enhancement factor allowed by SERS 
depends on the shape of the nanostructure, its resonances, and the electric field 
enhancement near the surface of the structure.24 For example, a nanoporous copper-
titanium film exhibited excellent SERS enhancement up to 107 when functionalized with 
Rhodamine 6G, a common Raman reporter dye.22 
With the development of nanoscale science and nanofabrication technology, a 
variety of nanostructures have been used for SERS applications. For SERS-based studies, 
common substrates are nanoparticles on a substrate,25 colloidal nanoparticles,26, 27  
metallic films,22 and nanohole arrays encased in a metallic film.28 Typical metals used for 
preparation of SERS substrates are silver, gold and copper.28-30 Classically, metallic 
nanostructured surfaces displaying surface roughness are utilized for SERS, similar to 
Fleischmann’s experiments.31 Since then, a variety of top-down and bottom-up 
fabrication techniques have been established for substrate fabrication. Bottom-up 
methodology involves self-assembly of individual material building components to 
generate larger nanostructures, whereas top-down methodology involves removal of bulk 
materials from a substrate to reveal desired nanostructures. Commonly, nanosphere 
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lithography is considered a top-down approach whereas electron beam lithography (EBL) 
is commonly used as a bottom-up approach.32 
1.1.1 Applications of SERS in Biology 
SERS is a powerful analytical technique for studying biological materials due to 
its non-destructive nature and ability to work in aqueous and dry conditions. As opposed 
to fluorescence measurements, Raman spectroscopy does not require staining and may 
therefore be used to obtain native molecular and chemical information pertaining to 
molecules. Molecular information pertaining to the symmetry and orientation molecules 
is useful for applications in polymer and materials sciences,33, 34 biochemistry,35, 36 
biosensing,37 and electrochemistry.38, 39 SERS-based biosensing has been exploited to 
detect diseases such as Alzheimer’s disease,40, 41 human immunodeficiency virus,42 and 
various cancers.43-45 SERS has additionally been used as a tool for studying cellular 
adhesion.46 pH sensing,47 glucose sensing,48, 49 and detection of bacteria.50, 51 
1.2 Biological SERS Detection Methodologies  
1.2.1 Indirect Detection methods 
 Detection methodologies for biological SERS applications may be grouped into 
direct and indirect methods. Indirect methods involve monitoring of a secondary analyte, 
known as a “Raman reporter”, which interacts with a species of interest upon 
introduction. The interaction of the secondary analyte with the species of interest is 
monitored spectroscopically by a change in peak intensity and/or peak position, which 
signals a successful binding event or interaction. These changes may be monitored to 
reveal quantitative information on the analyte of interest. Secondary analytes commonly 
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used for SERS are boronic acid esters,52 aptamers,53 and nucleic acids.54 Additional 
secondary analytes include 4-mercapto benzene thiol,55 4-amino benzene thiol,56, 57 and 
nile blue.58 
Boronic acid esters are also commonly used for SERS applications for saccharide 
detection. They form cyclic boronate esters with 1,2 and 1,3- diols, making them great 
candidates for detection of saccharides and sugars.59 More recently, boronic acid esters 
have been used for biosensing of sugars. For example, 4-mercaptophenyl boronic acid (4-
MPBA) has been used to sense fructose. Detection of fructose present in urine samples 
reported at millimolar concentrations based on peak intensity changes of 4-MPBA. The 
symmetry breaking of 4-MPBA upon fructose binding lead to a change in the relative 
ratio between the symmetric ring mode at and non-symmetric ring mode, signaling the 
successful binding of glucose.60  
4-MPBA has also been used for biosensing of glycan distribution across 
cancerous and non-cancerous cell lines based on its interaction with 1,2- and 1,3- diols of 
saccharides present in glycans.52 Monitoring of the relative intensity of two peaks 
corresponding to B-OH stretching and C-C phenyl stretching of the phenyl group of 4-
MPBA were studied to determine overall glycan distribution and expression on cellular 
surfaces. Biosensing capabilities allowed by 4-MPBA allowed for determination of an 
elevated glycan distribution in cancerous cell lines when compared to the non-cancerous 
cell line.  
Aside from commonly studied sugar and glycan detection, boronic acid esters 
have been used as reporters to detect biomolecules such as dopamine. For example, 
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quantitative detection of dopamine was reported in human cerebrospinal fluids by 
functionalization of gold nanoparticles with 3-MPBA.61 No SERS signal detected for the 
nanoparticle probes, however an intense SERS signal was gained upon introduction of 
dopamine, signaling a successful binding event.  
1.2.2 Direct Detection Methods  
Incorporation of a secondary analyte for indirect SERS monitoring of biologically 
relevant species has proven useful for studies across a wide variety of scientific 
subdisciplines. However, methods involving direct monitoring without the use of a 
secondary labelling agent are of great interest for clinical applications and for rapid, on-
site detection. Such methods typically involve use of metallic nanoparticles or roughened 
metallic surfaces for SERS acquisition, and are referred to as direct monitoring methods 
since SERS probes are placed in direct contact with the biomolecule(s) of interest.  
Use of metallic nanoparticles for direct SERS detection of biological species has 
proven useful for virus and disease detection. Gold nanorods have been used to directly 
monitor spectral differences of normal red blood cells compared to red blood cells 
(RBCs) infected with malaria virus at various stages of disease progression.62 Using 
chemometric analysis, peak changes were identified that corresponded to expected 
membrane alterations upon infection of cells with the virus. One of these membrane 
changes corresponded to a change in the relative ratio of amino acids to cholesterol, 
which after infection increased more than 4-fold compared to normal RBCs. Additional 
to viruses, cancer biomarkers have also been monitored using direct SERS detection 
methodology. Gold and silver nanoparticles were used recently to encapsulate and detect 
cytidine in urine, a biomarker indicative of early onset of colon cancer.63 Detection levels 
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at millimolar concentrations were reported, thereby confirming that SERS could be used 
to monitor cytidine for evaluation of colon cancer risk at early stages.  
Chip-based approaches have also been used for direct detection methodologies by 
SERS. Immobilization of bacteria onto a glass coverslip, followed by introduction of 
charged gold nanoparticles was used recently to differentiate and detect several types of 
gram-positive and gram-negative bacteria.64 Direct contact of NPs with the membranes of 
bacteria allowed for direct SERS sensing of nucleic acids, membrane proteins and 
membrane carbohydrates for each individual strain. Reproducible SERS spectra were 
acquired with a good signal-to-noise ratio and with low acquisition times. SERS-active 
substrates have been reported for direct SERS sensing of a variety of biological materials. 
For example, silver-coated nanohole arrays were utilized to trap biological vesicles 
released from an ovarian cancer cell line.31 Capturing of vesicles occurred without the 
need for antibodies or other anchoring proteins. Vesicles trapped within the nanoholes 
were probed by SERS, allowing for molecular-level characterization of nanometer-sized 
biological species.  
1.2.3 Scope of Thesis  
 This thesis is organized into five chapters. Chapter 1 introduces the field of SERS 
and outlines current work within this context for biological applications. Chapter 2 
focuses on experimental details of this thesis, providing in-depth background information 
into the physical, chemical and biological principles underlying this work. Chapter 2 also 
provides important information on the clinical relevance of this work. Chapter 3 outlines 
nanofabrication techniques to fabricate plasmonically active platforms for SERS and 
examines their ability to trap and probe nanoscale materials. Chapter 4 extends this work 
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to application-based sciences and presents results of probing spectral signatures from 
biological vesicles by SERS. Chapter 5 concludes this thesis with final remarks and 
future suggestions.  
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Chapter 2 
2 Extracellular Vesicles (EVs) 
Extracellular vesicles are secreted by nearly all cell types within the body and are 
present in nearly all our biofluids. They were previously believed to be junk materials 
released from cells but are now widely accepted to play diverse and functional roles 
throughout the body. This chapter introduces EVs, outlines their functions and describes 
some spectroscopic and biological methods that may be used to validate their presence 
and composition. 
2.1 History of EVs 
In 1946, Chargaff and West unknowingly discovered extracellular vesicles (a 
subgroup known as microvesicles) when they observed a precipitate factor present in 
platelet-free plasma.1 In 1967, Wolf described extracellular vesicles as ‘platelet dust,’ 
after discovering what he believed to be lipid ‘junk’ present in a fraction of a plasma 
sample following ultracentrifugation.2 Following their serendipitous discovery, scientists 
discovered that EVs were anything but dust. They have since been found to play 
important roles in the fields of immunology,3,4 cell biology,5,6 biochemistry,7, 8 
neuroscience,9,10 and ophthalmology.11,12 The intense interest in EVs has grown largely 
throughout the past decade, as shown in Figure 2.1  by the number of publications 
accepted to journals across scientific subdisciplines.  
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Figure 2.1 - Number of publications retrieved from webofknowledge.com 
mentioning ‘extracellular vesicle’ as of June 20, 2018  
2.1.1   Classification and Composition of EVs 
                 The umbrella term, ‘extracellular vesicle’ refers to three main types of 
vesicles: exosomes, microvesicles and apoptotic bodies. Nomenclature for classification 
of EVs has been under considerable debate in recent decades. Previously, EVs were 
solely classified based on the type of cell they were released from. For example, prostate-
cell derived vesicles were classified as prostasomes,13 whereas neuronal vesicles were 
classified as synaptic vesicles.14 However, a new classification system extended 
classification based on origin to size, allowing for universal comparison across cell lines. 
Exosomes (30 nm – 100 nm) originate from the cytoplasmic region of cells and are 
exocytosed into the extracellular environment upon fusion of multivesicular bodies 
(MVBs) with the plasma membrane of cells. Microvesicles are larger versions of 
0
200
400
600
800
1000
1200
1400
1600
1800
2000
2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
N
u
m
b
er
 o
f 
P
u
b
li
ca
ti
o
n
s
Year
14 
 
exosomes (50 nm – 1000 nm) and are released by membrane blebbing from the cellular 
surface. Apoptotic bodies are the largest class of EV (50 - 5000 nm) and are released 
during cellular apoptosis. In addition, these three classifications of vesicle separate into 
different fractions during ultracentrifugation due to their density differences. EV 
classification may occur based on size, density and origin as outlined in Table 1.  
Table 1 - Classification of EVs 
Type of EV Approximate 
Size (nm) 
Density 
(g/mL) 
Detection/ 
Characterization 
Origin/ Location of 
Release 
Reference 
Exosome 30 – 100 1.13 – 
1.19 
TEM, WB, FC, 
MS 
Exocytosis of 
multivesicular bodies 
15, 16, 17 
Microvesicle 50 – 1000 1.03 – 
1.08 
FC, SEM, TEM Plasma membrane 15, 18, 19 
Apoptotic 
Body 
50 - 5000 1.16 – 
1.28 
FC, SEM, TEM Plasma membrane or 
endoplasmic 
reticulum during 
apoptosis (cell death)   
15, 20, 21 
EVs have been found to play diverse and important roles in delivery of cargoes to 
target cells. These cargoes include functional proteins, growth factors, nucleic acids and 
lipids.22 Their roles include intercellular communication,23 signal transduction,9, 10 T-cell 
stimulation,4, 24 cancer metastasis25 and apoptosis.26 Due to their release from cells into 
their microenvironment within the human body, EVs may be isolated from biological 
fluids such as tears,27 urine,28 blood,29,30 and cerebrospinal fluid.31 A given cohort of EVs 
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released from a single parent cell may vary widely in composition and location of 
biomarkers. Study of their composition has previously been reported by fluorescence 
microscopy, scanning electron microscopy (SEM), transmission electron microscopy 
(TEM).32 mass spectroscopy(MS),33 flow cytometry (FC),15 western blotting (WB)34,35 
and atomic force microscopy (AFM).36            
2.1.2  Methods of Isolating EVs 
Ongoing studies seek to understand the modes of action as well as diverse 
functional roles of EVs. This information is necessary to better understand disease 
progression and their link to biomarker presence and distribution for a wide variety of 
diseases. A major challenge thus far in EV research is the lack of standardization in 
isolation of EVs. Advances have been noted in isolation techniques involving 
ultracentrifugation, differential centrifugation, microfluidics, filtration and 
chromatography. This section will focus mainly on isolation of EVs through 
ultracentrifugation and filtration.  
Ultracentrifugation (UC) is considered the gold standard of EV isolation. It is the 
most common method used has been reported to isolate EVs of varying size, density and 
origin, including from bodily fluids and conditioned cell culture media. The technique 
requires numerous centrifugation steps to isolate EVs from other biological matter such 
as dead cells and proteins. UC protocol typically begins with a low-speed centrifugation 
step, such as 300 g for 10 minutes to remove dead cells and larger apoptotic body debris. 
The proceeding steps vary amongst research groups, however protocols increase speeds 
in subsequent steps, between 1000 g to 20,000 g to remove larger protein debris and 
larger vesicles.37 The final centrifugation step involves a spin at 100,000 g to precipitate 
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EVs to the bottom of the vial, after which supernatant is removed and the EV isolate is 
resuspended in phosphate buffered saline, or water in some cases.38  The technique has 
been successful at isolating exosomes and microvesicles, however apoptotic bodies have 
been reported less commonly in the literature, especially upon resuspension with water 
rather than buffer.  
Though UC is a gold-standard technique for isolation of EVs, it suffers from long 
isolation times, often requiring 4 – 6 hours for complete. In addition, it is difficult to 
optimize isolation protocols due to the large variety in sample compositions from various 
biofluids or cell cultures. Previous literature has also reported loss of important exosomal 
proteins and RNAs following UC, indicating loss of important biomarkers for study of 
disease progression and diagnosis.39, 40  
Filtration techniques are often reliant on centrifugation steps to remove dead cells 
and debris and may minimize time compared to UC. Following initial centrifugation, 
filters or membranes may be used to sort EVs from remaining media or biofluids. For 
example, Campoy et al. successfully isolated vesicles from uterine cells for study of 
endometrial disorders by incorporating a 200-nm filter following a 10,000 g 
centrifugation for 30 minutes.41 Applying this method, the group concluded successful 
exosomal isolation by SEM and immunoblotting. Filtration through chromatography 
columns has also previously been reported following centrifugation steps.42 Although 
filtration techniques have proven successful in isolation of EVs, they are still reliant on 
centrifugation. In addition, pores and membranes may become clogged during isolation, 
meaning re-use of filters is highly discouraged.  
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Specificity in isolation of EVs based on biomarkers may be achieved using 
magnetic beads coated antibodies specific to antigen present on the surface of EVs, or 
antibody coated microfluidic devices.41 However, complete isolation of EVs from other 
biomaterials remains as a challenge since origin of samples varies widely.  
2.1.3 EVs as Human Liquid Biopsies 
In past years, definitive determination of disease diagnosis occurred mainly 
through tissue biopsies. Through surgical procedures, a suspected sample would be 
removed for biopsy through microscopic and analytical means. Tissue biopsies provide 
useful information to the clinician and patient, however the means of obtaining such 
samples are often time consuming, invasive, costly and risky to the patient. Additionally, 
tissue biopsies mainly provide site-specific information, and do not allow for 
differentiation of additional diseases that may be present at locations in a given body or 
system.  
Movement towards liquid biopsies reduces many of the drawbacks of tissue 
biopsies. Liquid biopsies are acquired by collection of blood, urine, tears or saliva. Their 
modes of collection are less invasive compared to tissue extraction as they are collected 
by needle extraction (blood collection), or by simple collection (urine and tear 
collection). These methods minimize sample acquisition time, harm to the patient and 
provide additional insight into overall human health since they carry DNA, platelets and 
microparticles released from other effector areas of the body. The biofluids undergo 
sample preparation protocols to isolate for vesicles, DNA, platelets and other materials of 
interest. These biopsies allow for molecular analyses very similar to those allowed by 
tissue samples while providing many benefits to the patient. 
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Extracellular vesicles, specifically exosomes have been studied in great depth due 
to their small size and great stability in liquid environments. The lipid bilayer 
surrounding exosomes protects the internal cargo from degradation allowing for study of 
their internal contents.43 Additionally, the internal and external biomarkers reflect those 
of the cell of their origin, providing a means of studying cell biology while eliminating 
complex cellular machinery such as a nucleus or golgi apparatus, which is exceptionally 
valuable for spectroscopic studies.  
2.1.4 Spectroscopic Studies of EVs 
Study of EVs by vibrational spectroscopy allows for study of cellular biomarkers 
without bulky cellular machinery. In human health studies, analysis of biomarkers 
present internally and externally in EVs may provide information on stage and degree of 
disease progression. This information has been probed using Raman,44 SERS,23, 45, 46 and 
Fourier-transform infrared spectroscopy (FT-IR).47 
Through analysis of the spectroscopic signature of EVs derived from cancerous 
and non-cancerous origins, it may also be possible to generate a library spectroscopic 
peaks outlining the variation and common cargoes among cell lines. For example, when 
comparing cancerous and non-cancerous lines of EVs, some expected conserved 
spectroscopic peaks (listed peaks are SERS peaks) may be chain C-C stretches in lipids 
from the phospholipid bilayer (700 cm-1), CH2 and CH3 deformations from proteins and 
lipids (1450 cm-1), C=C stretches in lipids (1651 cm-1), and amide II vibrations in 
proteins (1480-1575 cm-1). In contrast, peaks corresponding to nucleic acids and proteins 
such as C-C stretching from proline and valine (930-940 cm-1) and asymmetric phosphate 
stretching (1245 cm-1) would be expected to vary. 
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2.2 Principles of Surface-Enhanced Spectroscopies 
2.2.1 Plasmon Resonances in Metal  
Metallic materials consist of charges (free electrons) that may be placed into 
motion by coupling of an oscillating electromagnetic field polarized in a defined 
direction. This phenomenon is defined within the field of plasmonics, which aims to 
control the coupling of an electromagnetic field with the free electrons in the conduction 
band of a metals. Plasmons are exploited widely in spectroscopy, in a subfield known as 
molecular plasmonics.48 Many studies in molecular plasmonics utilize metallic 
nanostructures to exploit the local electromagnetic enhancement near the surface of the 
conductive surface or metal. Some of these fields are surface-enhanced Raman 
spectroscopy (SERS), tip-enhanced Raman spectroscopy, surface-enhanced fluorescence, 
surface enhanced infrared absorption.  
2.2.2 Surface Plasmon Polaritons (SPP) 
A surface plasmon polariton (SPP) is defined as a collective fluctuation in 
electronic density at the interface of a metal and a dielectric. The oscillation frequency of 
free electrons is dependent on the type of metal and the surrounding dielectric medium. 
Additional factors such as the size of the metallic structure, shape of metallic structure 
and the distance between adjacent metallic structures must also be taken into 
consideration. Surface plasmon waves are tightly confined to the interface between a 
metal and a dielectric. The intensity of a SP decays exponentially away from the surface. 
The decay length (i.e. the distance between maximum and minimum field) into the 
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dielectric medium may be estimated by λ/2n  where n is the refractive index of the 
dielectric.49 
Dielectric
Metal
+ + +-  -  - 
z z
x x
~ λ / 2 n 
 
Figure 2.2 - (a) Schematic of the charge distribution and local electric field 
associated with surface plasmons; (b) The strength of the SP decays exponentially 
with increasing distance from the metal and dielectric 
2.2.3 Localized Surface Plasmon Resonance  
A condition known as surface plasmon resonance occurs when the frequency of 
incoming light exactly matches that of the frequency of oscillation of surface plasmons. 
In the case where a surface plasmon interacts with a nanostructure smaller than the 
wavelength of incident light, the surface plasmon becomes confined to the nanostructure, 
generating a localized surface plasmon resonance (LSPR). In LSPR, the free electrons in 
the metal oscillate with respect to the induced electric field causing the momentum and 
wavevector of the nanostructure to change.  
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Figure 2.3 – Localized surface plasmon resonance of a metallic nanoparticle 
Bulk surface plasmons are differentiated from localized plasmons when working 
with nanoparticles or nanostructures on the sub-wavelength size scale. LSPR modes are 
dependent on the metal type as well as the size and shape of the structure.50 The 
localization of an incident electromagnetic field near the surface of metallic 
nanostructures is the basis of many surface-enhanced techniques. 
2.2.4 Raman Spectroscopy 
Raman spectroscopy is a spectroscopic technique used to observe vibrational 
modes of molecules that compose a material or a biomaterial. It is a label-free technique 
offering molecular information from inelastically scattered light. The interaction and 
scattering of light off a molecule or biomolecule of interest provides information on the 
molecular composition of the system and, when used in conjunction with polarized 
measurements, can lead to the determination of molecular orientation at surfaces Raman 
spectroscopy is a powerful technique used to study biological and chemical systems, and 
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has also been used in the literature to analyze commonalities and differences amongst 
extracellular vesicles from cancerous and non-cancerous origins.51, 52 
When light impinges onto a molecule or particle of interest, a majority of the light 
is elastically scattered. This is the most common form of scattering, known as Rayleigh 
scattering. Rayleigh scattering occurs when scattered light is emitted at the same 
frequency (v0) as the incident light. 1 in every 10
8 photons of incident light scatters 
inelastically by emitting with a higher or lower frequency compared to the incident 
radiation. This shift of energy is known as a Raman shift. Lower energy, or higher 
wavelength photons are known as Stokes-shifted photons, whereas higher energy and 
lower wavelength photons are known as anti-Stokes shifted photons.  
Rayleigh Scattering
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Figure 2.4 - Illustration of the various elastic and inelastic scattering paths an 
emitted photon may undergo following interaction with a molecule of interest  
The various scattering paths a photon may take upon interaction with a molecule 
of interest are outlined in Figure 2.5, where v0, v1 and v2 indicate various vibrational 
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states of a molecule. Elastic transitions with no net change in energy (such as v0 to v0 
transitions) indicate Rayleigh transitions. Inelastic transitions resulting in photons of 
higher wavelength (v1 to v0) or lower wavelength (v0 to v2) indicate Raman-active 
transitions. Stokes-shifted photons occur more frequently than anti-Stokes shifted 
photons due to the probability distribution of molecules occupying excited and ground 
state vibrational modes at any temperature, modelled by the Boltzmann distribution 
curve.53 At room temperature, most molecules exist in their ground energy state while 
only a small fraction exist in an excited vibrational or rotational state.  
Although Raman spectroscopy is a well-adapted technique for biological and 
chemical studies, it has an intrinsic weak sensitivity due to the poor scattering cross 
section of materials. Fortunately, the Raman signal may be enhanced by using surface-
enhanced Raman spectroscopy (SERS) techniques.  
2.3 Surface-Enhanced Raman Spectroscopy (SERS) 
2.3.1 Electromagnetic Mechanism of SERS 
Two mechanisms, the chemical and electromagnetic mechanisms are responsible 
for the SERS enhancement. The electromagnetic mechanism of SERS is a direct result of 
the localized surface plasmon resonance (LSPR) of metallic nanoparticles. Upon 
interaction with the oscillating electromagnetic field of light, the free electrons in the 
conduction band of a metallic nanostructure become polarized and generate plasmons in 
the electron cloud of the metal.50 At specific frequencies, the oscillation of the metallic 
nanostructure will be in resonance with the frequency of the incident light, generating a 
LSPR oscillation. Through control of the size, shape, type of metal and the local 
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dielectric environment of the metallic NPs, one can fine-tune the resonance condition, 
location and strength of the LSPR from visible to near-infrared ranges. The enhancement 
factor allowed by the electromagnetic mechanism may be approximately quantified using 
equation (1):  
E= |E(w)|2 |E(w’)|2    (1) 
Where E is the enhancement factor, E(w) is the local electric-field enhancement factor at 
the incident frequency, w, and E(w’) is the Stokes-shifted enhancement factor at 
frequency w’. E is often estimated by assuming E(w) and E(w’) are the same, leading to 
an overall enhancement factor of E(w)4.54 
To demonstrate the enhancement of the Raman signal by SERS, experimental 
Raman and SERS spectra of malachite green (MG) are shown below (Figure 2.5). 
 
Figure 2.5 – SERS (red) and Raman (blue) spectra of malachite green 
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The enhancement allowed by the chemical and electromagnetic enhancement 
mechanisms of SERS is visibly considerable. The characteristic Raman peaks of MG 
were comparable to the literature. For example, the N-C bonding and C-C stretching 
vibrations were observed at 1617 cm-1. Additionally, the bands at 1173 and 1294 cm-1 are 
assigned to aromatic C-H bending vibrations.55 The SERS spectrum was obtained by 
dilution of MG powder to 1 mM in ethanol and placement onto a SERS-active substrate 
prepared by lithography. The Raman spectrum was obtained by placement of bulk MG 
powder onto a glass coverslip. 
2.3.2 Chemical Enhancement Mechanism of SERS 
The chemical enhancement (CE) mechanism is still an active area of study and is 
not yet completely understood. It is thought to occur due to formation of a bond between 
an adsorbed molecule and a metal. Three distinct phenomena, known as (1) charge-
transfer chemical enhancement, (2) resonant Raman enhancement and the (3) non-
resonant Raman enhancement mechanisms have been proposed, which work in tandem to 
generate the effect.56  
2.4 Preparation of Plasmonic Platforms by Nanosphere 
Lithography 
A common method for fabricating semi-reproducible plasmonic substrates for 
collection of SERS spectra is by nanosphere lithography (NSL). NSL is a bench-top 
technique reliant on the self-assembly of nanoparticles in hexagonally arranged arrays. 
Following self-assembly on a substrate such as quartz, glass or silicon, metal is deposited 
and nanoparticles are gently removed by sonication revealing triangular nanostructures 
that are SERS active. These structures have previously been fabricated by members of the 
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Lagugné-Labarthet research group and have been reported in the literature for analyte 
detection57 and mapping of cancerous biomarkers in different cell lines.58 
 
Figure 2.6 – Schematic of NSL fabrication, with top and side views 
NSL offers the ability to fabricate large SERS-active domains several microns in 
size. In some cases, areas of coverage have also been reported as centimeters in size.59 
However, nanosphere lithography suffers from low reproducibility and homogeneity, and 
offers limited variations of structures that may be fabricated.19 Figure 2.7 outlines 
structures fabricated by NSL of 1.00 µm polystyrene microspheres by SEM. Figures 2.7 
(A, B) illustrate desired nanostructures with well-defined tips at triangle apexes. The 
sharp apices of nanotriangles have been characterized previously to generate the 
maximum SERS enhancement.60 Challenges in achieving uniformity of the 
nanostructures is highlighted in Figure 2.7 C). In the right-half of this image, the 
polystyrene distributed into a monolayer formation whereas on the left-half of this image, 
a bilayer of polystyrene assembled. Lift-off of the bilayer of PS revealed nanostructures 
that are non-uniform in size, shape and spacing.  
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Figure 2.7 -  SEM images of nanostructures prepared by NSL; A, B) Top view of 
nanostructures following lift-off; C) Boundary between a bilayered area and 
monolayered area following lift-off of nanospheres 
Classic structures generated by NSL are the nanoprisms. Other nanostructures fabricated 
by NSL are nanopyramids,61 film-over-nanosphere,62 Moire patterns,63 nanohole arrays,63 
nanocrescents64 and nanobowls.65 
2.4.1 Preparation of Plasmonic Platforms by Electron Beam 
Lithography 
To overcome many of the challenges of NSL, electron beam lithography (EBL) is 
considered a competitive technique. It offers many benefits over NSL namely precise 
control over the sizes and shapes of patterns for fabrication of plasmonically active 
substrates. It is also highly reproducible compared to NSL. EBL typically employs a 
scanning electron microscope, and an electron beam that is precisely scanned across a 
photoresist to generate a pattern. Photoresists are either ‘positive’, or ‘negative’, meaning 
areas exposed to the electron beam will either become more or less soluble when exposed 
to a developing solution. Positive resists undergo bond breaking in areas exposed to the 
electron beam, therefore producing a pattern that is the same as the pattern outlined by 
the electron beam (positive image), whereas negative resists undergo bond-making in 
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exposed areas, producing the reverse (negative image) as the pattern outlined by the 
electron beam. Following electron irradiation, exposed areas in a positive resist dissolve 
in developing solution (generally an organic solvent) whereas exposed areas in the 
negative resist are maintained. Incorporation of metals such as gold and silver may be 
deposited to allow for propagation of plasmons and SERS capabilities.  
 
Figure 2.8 - Schematic illustration of electron beam lithography process performed 
on a positive and negative resist.66 
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2.4.2 Characterization of Plasmonic Platforms 
To characterize plasmonic platforms, the absorption spectra are typically acquired 
to determine the optimal wavelengths of LSPR excitation. The LSPR excitation 
wavelength maximum (λ max) is sensitive to a variety of factors including the dielectric 
constant of the metal, the refractive index as well as the structure and shape of the 
metallic nanostructures. Therefore, any changes in metal type, thickness, or substrate 
should lead to acquisition of an absorption spectra for characterization of λ max. 
 
Figure 2.9 – Schematic of absorption spectra setup enabling the measurement of 
plasmon resonances of the nanostructured surfaces over a surface limited to a few 
tens of microns.  
Figure 2.8 illustrates a schematic of the apparatus used to obtain an absorption 
spectrum. The area required to obtain an absorption spectrum is typically 40 – 100 
microns in diameter. The home-build setup involves use of a white light source (halogen 
lamp), which is conducted through an optical fiber (100 µm diameter) to a series of 
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objectives to reduce the size of the probe beam yet keeping it parallel. These objectives 
lead the transmitted light to a spectrometer and ultimately to a charge-coupled detector. 
This allows for measurement of the intensity of light upon reaching the spectrometer. The 
light transmitted is measured as a function of incident wavelength, allowing calculation 
of the ratio of transmitted intensity (I) versus initial intensity (I0) and expressed in units 
of absorbance (abs=-log(I/I0). 
2.5 Summary 
This chapter outlines the biological makeup and clinical relevance of extracellular 
vesicles. In addition, the physical principles underlying lithographic techniques proposed 
for the characterization of EVs are highlighted. Lithographic techniques may be used to 
fabricate nanostructures compatible with surface-enhanced Raman spectroscopy, a 
technique based off the inelastic scattering of light. The low scattering cross-section of 
inelastically scattered light may be enhanced within plasmonic fields generated at the 
surface of a noble metal upon illumination with a monochromatic laser source coupled 
with the resonant wavelength(s) of the nanostructures. This provides the basis of surface-
enhanced techniques and allows for detection of analytes down to the single-molecule 
level. The mechanisms responsible for this enhancement, known as the chemical and 
electromagnetic mechanisms are also discussed in detail. 
Fabrication of metallic platforms prepared by lithography are proposed for study 
of biological nanomaterials known as extracellular vesicles. Two lithographic techniques, 
nanosphere lithography and electron beam lithography are discussed in this realm. NSL is 
a well-characterized technique for fabrication of large areas of nanostructures and is 
proposed for probing of the bulk SERS spectral signatures of EVs. Electron beam 
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lithography is further proposed for controlled fabrication of nanostructures and probing 
of individual spectral signatures of EVs. This work ultimately seeks to apply well-
characterized nanofabrication techniques to study a novel biological application in a 
promising field. 
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Chapter 3  
3 Fabrication and Characterization of Plasmonic 
Platforms 
This chapter explores the fabrication of plasmonic platforms by nanosphere 
lithography and electron beam lithography. The materials and methods used to fabricate 
and characterize these platforms are described in detail. The use of plasmonic platforms 
is presented within the scope of their desired application, to study biological vesicles. 
3.1 Introduction 
Advances in nanofabrication have allowed for fabrication of nanostructures with a 
high degree of control over the size, the shape, the geometry and the chemical properties 
of the materials. As such, several lithographic methods have been developed to fabricate 
nanostructures. These methods are typically classified into two groups, namely top-down 
or bottom-up fabrication.1 Top-down approaches in nanofabrication such as electron 
beam lithography aim to carve large-scale materials to micro- and nano-size features 
using lithography or focused ion-beam methods.2-4 These approaches have proven 
successful in producing features less than tens of nanometers in size with high precision 
and resolution due to advances in photoresist technologies. In contrast, bottom-up 
processes such as wet chemical synthesis or nanosphere lithography rely on increasing 
the size of a primary building block to generate ordered nanomaterials on a larger size 
scale.5-7  
Metallic nanostructures have been studied for a wide variety of applications using 
surface plasmon resonance (SPR),8, 9 extraordinary optical transmission (EOT),10, 11 
surface-enhanced infrared absorption spectroscopy (SEIRA)12-14 and surface-enhanced 
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Raman spectroscopy (SERS).15-18 One particularly interesting subclass of nanostructure 
previously characterized by the aforementioned technologies is nanohole arrays (NHAs). 
NHAs have been fabricated by a variety of methodologies. One commonly reported 
method of fabricationg NHAs is based on self-assembly of polystyrene spheres followed 
by an etching process, metal deposition and subsequent lift-off of nanospheres.19, 20  This 
methodology is successful in generating areas of nanohole arrays, with nanowells 
corresponding to one dimension in the areas where nanospheres were originally placed.21 
However, the self-assembly of polystyrene often leads to defective areas and allows for 
minimal control over the spacing and sizes of individual nanowells. Therefore, 
methodologies such as focused ion beam lithography,22, 23 interference lithography,19, 24 
and electron beam lithography25, 26 are typically preferred to increase control over sizing 
and spacing. 
A significant advantage provided by nanohole arrays arises from their ability to 
trap and probe materials in confined nanowells. Fabrication of nanohole arrays by 
interference lithography has been reported in the literature previously for detection and 
trapping of biological proteins.19 For example, when a protein was introduced into 
nanowells fabricated by laser interference lithography, optical transmission images 
revealed confinement of proteins to the nanowell areas.19 Channels filled with trapped 
protein(s) appeared darker in colour upon illumination, whereas channels free of protein 
would appear bright under transmissive light settings. Successful trapping of proteins was 
therefore achieved and validated. Laser interference lithography is a great technique for 
fabricating nanostructures, however it is limited by the resolution of the light source, 
which in this case was a UV source. Nanostructures are therefore limited by size due to 
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the resolution of the light source. In this case, structures may be resolved to 200 nm and 
larger. In cases where features less than 200 nm are desirable, an electron beam source 
may be employed to generate high resolution nanostructures down to ~ 50 nm in size.  
Recently, plasmonic nanohole arrays have been incorporated into chip-based 
sensing for detection of biomaterials. For example, integration of NHAs fabricated by 
UV-lithography with an adjustable microfluidic cell module have been reported for 
direct, real-time detection of a growth factor released from live under controlled cell 
culture conditions.27 Chip-based devices with integrated nanohole arrays hold great 
potential in point-of-care diagnostic testing for human health studies. The work presented 
throughout this chapter aims to fabricate NHAs in a reproducible manner to probe 
microvesicles released by cells.   
3.2 Experimental  
3.2.1 Materials for Nanosphere Lithography 
Cover slips were obtained from VWR International (22 mm x 22 mm x 0.15 mm) 
and subjected to acid/base cleaning to yield a pristine surface onto which are formed NSL 
patterns. Coverslips were suspended in acetone (Sigma Aldrich), sonicated for 5 minutes 
and gently rinsed with ultrapure water. They were subsequently sonicated in a solution of 
Nochromix® (Godax Laboratories Inc., Maryland U.S) and sulphuric acid for 20 
minutes. After rinsing with milli-Q water (18.2 MΩ.cm), they were sonicated in a 1:1:5 
solution of ammonium hydroxide: hydrogen peroxide: milli-Q water for 60 minutes. NSL 
was adapted from a previously outlined protocol.28 A 1 cm diameter O-ring was utilized 
with a 1:25 v/v ratio of 1 μm polystyrene microspheres to water (10% w/w polystyrene, 
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ThermoFisher Scientific, California, U.S.). 20 μL of the polystyrene mixture was drop 
casted into the O-ring and allowed to dry for 12 hours. Monolayer coverage was verified 
optically, and the substrates were subsequently coated with a 3-nm adhesion layer of 
titanium and 30 nm of gold. Lift-off of polystyrene spheres was performed in acetone 
(Sigma Aldrich) with mild sonication for 10 – 30 seconds.  
3.2.2 Materials for Electron Beam Lithography 
3.2.2.1 Polymethymetacrylate (PMMA) Nanohole Arrays 
Microscope coverslips were subjected to reactive O2 plasma for 10 minutes. A 
positive resist, 495-PMMA-A4 (Microchem, Westborough, MA) was spin coated onto 
the substrate surface at 3000 rpm corresponding to a thickness of 1800 Å, respectively.23 
Substrates were baked for 90 seconds at 180 °C. Aquasave® conductive polymer 
(Mitsubishi Rayon Co.) was spin coated onto the PMMA surface as a conductive layer 
and subsequently baked at 110 °C for 2 minutes. Electron-beam lithography was 
performed using a LEO 1530 SEM microscope with electron beam capabilities. Patterns 
of arrays were designed with varying sizes (0.1 - 1.0 μm, with a 0.1 μm step in between 
sizes) and varying shapes (circle and square) using a CAD software (NPGS), and all 
patches of patterns measured 50 μm x 50 μm2. A standard procedure using a 1:3 solution 
of methyl-isobutyl ketone and isopropanol allowed for development of arrays and 
removal of the resist that was exposed to the electron beam. 
3.2.2.2  Metallic Nanohole Arrays 
 Microscope coverslips were subjected to reactive O2 plasma for 10 minutes, after 
which a negative resist, Ma-N 2405 (Microchem, Westborough, MA) was spin coated 
onto the substrate at a spin speed of 3000 rpm, corresponding to a thickness of 
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approximately 6300 Å, and baked for 90 seconds at 90 °C. AquaSAVE conductive 
polymer (Sigma-Aldrich) was spin coated at 3000 rpm as a conductive layer and 
subsequently baked at 90 °C for 45 seconds. Electron-beam lithography was performed 
using a LEO 1530 SEM microscope with electron beam capabilities. Patterns of arrays 
were fabricated of varying sizes (0.1 - 1.0 μm, with a 0.1 μm step in between sizes) and 
varying shapes (circle, triangles and square) using a CADsoftware(NPGS), and all 
patches of patterns measured 50 μm x 50 μm2. Following lithography, samples were 
developed in MF-319 developer (MicroChem, Westborough, MA) for 30 - 45 seconds. 
Samples were subjected to a 30-second O2 plasma descum process to remove residual 
resist surrounding nanopillars. A 3-nm adhesion layer of titanium was then deposited 
followed by a 30-nm layer of gold by electron beam evaporation (Angstrom 
Engineering). Lift-off was allowed by exposure to remover-PG, a common photoresist 
remover heated to 80 °C (MicroChem, Westborough, MA) for 90 minutes to two hours, 
depending on the sample. Samples were subjected to a 1:3 solution of methyl isobutyl 
ketone and isopropanol to remove remaining remover-PG. Samples were then subjected 
to Nanostrip, a stabilized formulation of sulfuric acid and hydrogen peroxide compounds 
often used for removal of positive and negative photoresists (Cyantek, California, U.S.A) 
heated to 80 °C for 30 minutes and placed in water for 15 minutes to remove remaining 
nanostrip. Lastly, samples were subjected to O2 plasma for 5 minutes to remove 
remaining resist from inside metallized nanoholes.  
3.2.3 Raman and Surface-Enhanced Raman Spectroscopy 
A LabRAM HR (Horiba Scientific, NJ, USA) spectrometer was utilized for 
Raman and SERS spectroscopy. The spectrometer was equipped with a liquid nitrogen 
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equipped charge-coupled detector (CCD), and the excitation source was a helium-neon 
laser with a wavelength of 632.8 nm. A 100 × objective (N.A 0.9) was used to collect 
backscattered light. Laser power was set to ~ 0.5 mW and acquisition time varied 
between 20 – 200 s depending on the sample. A confocal pinhole of 200 µm and grating 
of 600 grooves /mm were used for these measurements.  
3.2.4 Fluorescence Imaging 
Fluorescence imaging was performed with a Zeiss LSM 510 META Multiphoton 
Confocal Laser Scanning Microscope. A Zeiss 63 × (N.A. 0.75) air objective as well as a 
632.8 nm He-Ne Laser were employed.  
3.2.5 Functionalization of Nanohole Arrays 
Samples were functionalized for 24 hours in a 10-3 M solution of 4-MPBA (4-
mercaptophenylboronic acid) in ethanol for preliminary testing. A helium neon laser (λ = 
632.8 nm) was used as the excitation source, and a 100 × (NA = 0.9) objective was used 
to collect back-scattered light. A mapping stage was employed to map the surface 
surrounding individual nanoholes measuring 0.9 μm in diameter for both square and 
circular shapes, and acquisition time was 5 s per pixel. 
3.3 Results and Discussion 
3.3.1 Characterization of Platforms Prepared by Nanosphere 
Lithography 
Several methods were tested to prepare NSL platforms such as drop-casting, air-
water interface or spin-coating. The O-ring method was selected due to its facile 
implementation and the desire to improve the method by manipulation of dilution ratio.28 
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Figure 3.1 outlines the O-ring method, highlighting the placement of polystyrene solution 
inside a 1-cm diameter O-ring and the subsequent self-assembly of polystyrene spheres (1 
μm diameter, 10% w/w, ThermoFisher Scientific, California, U.S.) following 12 hours of 
drying time.  
 
Figure 3.1 – Photographs of the O-ring method of NSL (A) prior to drying and (B) 
after 12 hours of drying time, prepared with 1 μm diameter polystyrene spheres. 
The dilution ratio of 1 μm diameter polystyrene spheres to milli-Q water was 
initially varied between 1:15, 1:20, 1:25, and 1:50. The best ratio to fabricate the larger 
areas of spheres monolayer was determined to be 1:25 by optical assessment of 
monolayer packing. This ratio lead to well-packed and high-density monolayered areas of 
polystyrene spheres. The characterization of the resulting NSL substrates were done 
using by scanning electron microscopy (SEM) and UV-Vis spectroscopy.   
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Figure 3.2 – Characterization of NSL nanostructures fabricated using 1-micron 
spheres by (A) SEM (B) absorption spectra. 
As illustrated in Figure 3.2 A), areas of packed polystyrene spheres allow for 
fabrication of regular nanostructures (nanoprisms) with sharp, well defined apices. 
Previous research on nanoprisms prepared by NSL has demonstrated confinement of the 
EM field occurs at apices, accounting for most of the plasmonic enhancement for SERS-
based applications.29 To obtain the most intense SERS enhancement from the NSL 
substrate, it is important to match the wavelength of the incident laser with the plasmon 
wavelength of the platform. Therefore, the absorption spectra of a NSL substrate is 
shown in in Figure 3.2 B). From this graph, the LSPR frequency appears to lie between 
630 - 650 cm-1, presenting similar results to those previously reported in the literature.30 
Matching of the incoming laser source within this range will allow for the best SERS 
signal.  
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3.3.2 Preparation of Plasmonic Platforms by Electron Beam 
Lithography 
To overcome many of the challenges of NSL such as the presence of defects, 
electron beam lithography (EBL) is a great alternative. In particular, it allows for control 
over shapes, sizing and spacing of nanostructures and provides excellent 
reproducibility.31 EBL employs the electron beam of a scanning electron microscope to 
scan the surface of a photoresist along defined sets of spatial coordinates. Photoresists 
vary between positive or negative types.32 Incorporation of metals such as gold and silver 
may be deposited following development to allow for propagation of plasmons and SERS 
capabilities. 
In this project, nanohole arrays were fabricated with both, positive and negative 
resists to ultimately test the ability to trap and probe nanoscale materials. The positive 
resist was non-metallized and was solely fabricated for trapping of nanoscale materials, 
whereas the negative resist was fabricated with a different protocol and metallized, 
allowing for SERS acquisition of trapped nanomaterials. Circular and square nanowells 
were fabricated with varying size. The size ranged between 0.1 – 1 μm, with a 0.1 μm 
step/increase in size between adjacent patterns, with the same sizes, shapes and 
parameters for both resist forms. Fig. 3.3 displays dark-field images of both types of 
fabricated arrays, obtained with a Zeiss Axioskop2 MAT microscope.   
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Figure 3.3 - (A) NHA fabricated with a positive resist for assessment of trapping 
abilities of NHAs; (B) Close-up of positive resist-fabricated 0.9 μm diameter circular 
nanowells; (C) NHA fabricated with negative resist, coated with 30 nm of gold prior 
to lift-off of nanopillars; The different colors of the individual patches indicate 
distinct plasmon frequencies (D) Close-up of negative resist-fabricated 0.9 μm 
diameter circular nanopillars; (E) NHA fabricated with negative resist, coated with 
30 nm of gold following lift-off of nanopillars, revealing nanowells; (F) Close-up of 
negative resist-fabricated 0.9 μm diameter circular nanowells. 
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Nanostructures revealed shapes and sizes of desired dimensions. For example, 
array number 10, enlarged in Fig. 3.3 (B) displays evenly shaped and sized nanowells, of 
dimensions 0.9 μm. The precise control of shape and sizes, as well as their high 
resolution indicate some of the benefits of electron beam lithography over nanosphere 
lithography.  
The variety of colours seen in in 3.3 C) under the same illumination conditions 
are indicative of varying sizes and shapes of nanostructures and are known as plasmon 
resonances.33 Nanostructures of different shapes, but of the same dimensions will reflect 
and scatter light such that the waves of given frequencies will constructively interfere, 
giving rise to colour.34, 35 This phenomenon is known as structural colour, and varies 
from traditional colouring since the colour does not arise from the use of pigments. The 
colours visualized are dependent on four main factors, namely the size, shape, dielectric 
environment and illumination conditions.36 In other terms, changing the size and shape of 
nanostructures changed the local refractive index, ultimately changing the colours 
associated with the samples.  
Initial characterization of metallic nanohole arrays by optical imaging was helpful 
to ensure successful fabrication of desired nanostructures. However, scanning electron 
microscopy was still required for full device examination. For example, during initial 
fabrication steps involving nanopillars, nanostructures < 400 nm in size are difficult to 
observe with a 100 × (N.A 0.9) objective. Additionally, different sized nanostructures 
may require different area doses for optimal fabrication. Structures inscribed with a dose 
greater than the optimal/nominal dose could display cracking, breaking, and may produce 
structures larger than desired. In addition, deposition of metal on top of nanostructures 
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could potentially lead to destruction of nanostructures due to the heaviness of metal 
deposited, an observation best viewed under SEM conditions. Lastly, developing 
nanostructures in solvent following lithography can cause removal of nanostructures if 
the adhesion force between the nanostructure and substrate is weak. Removal of 
nanostructures following developing in solvent would also be difficult to observe 
optically for nanostructures tens of nanometers in size. SEM is therefore required to 
assess these factors. 
 
Figure 3.4 - SEM nanopillars and nanowells. (A) 200 nm circular nanopillars; (B) 
900 nm circular nanopillars; (C) 900 nm square nanopillars; (D) 300 nm circular 
nanowell; (E) 700 nm circular nanowells; (F) 600 nm square nanowells. 
Figure 3.4 displays SEM images of nanopillars and resultant nanowells following 
lift-off. A dose test was performed for all sizes and shapes of nanopillars to determine the 
optimal electron beam energy density for each nanostructure. Optimal doses for circular 
and square nanostructures are outlined in Table 2. Study of optimal doses for each 
nanostructure was important to ensure for ideal resolution and correct sizing of structures. 
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When a pattern becomes exposed at a lower dose than the optimal dose for best 
resolution, this pattern is said to be underexposed. Underexposure may lead to a structure 
width smaller than the desired structure width, and has also been found to increase the 
probability of pattern irregularities.37 In contrast, exposing the nanostructure to a higher 
dose, or overexposing (dosage is higher than the optimum dose) may lead to a widening 
of the structure size. Tailoring the exposure dose for each nanostructure allowed for 
fabrication of structures of desired width and shape.  
Table 2 - Optimal electron beam dosage for fabrication of nanostructures of desired 
sizes 
Size (μm) Dosage (μC/cm2) 
0.1 100 
0.2 110 
0.3 105 
0.4 110 
0.5 – 1  90 
Using the nanopillars shown in Figure 3.4 (A – C), nanoholes were produced in a 
30 nm gold metal film. Following lift-off of nanopillars, SEM was used to validate 
cleanliness of this the procedure. Important factors to assess were definition of edges of 
nanostructures as well as residual resist remaining in nanowells. The lift-off procedure is 
further illustrated in Figure 3.5, where (A) illustrates the intact nanopillar, (B) illustrates 
lift-off with resist remaining in nanowells and (C) shows ideal structures with full 
removal of resist.  
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Figure 3.5 – Lift-off of nanopillars. (A) Intact nanopillar followed by (B) lift-off 
revealing residual resist in nanowells, which is removed fully in (C), showing 
exposed glass nanowells. 
Any residual resist remaining in nanowells such as in Figure 3.5 B) could 
interfere with materials sensed in welled areas during vibrational spectroscopic 
acquisition. The protocol for removal of residual resist therefore incorporated nanostrip, a 
formulation of sulfuric acid and hydrogen peroxide to remove this material without 
damage to the gold metal film. Reactive plasma O2 treatment was additionally 
incorporated to further remove/descum remaining resist in welled areas. This treatment 
revealed clean lift-off of nanopillars and well-defined nanowells, indicating successful 
fabrication of desired structures. 
3.3.3 Plasmonic Properties of Metallic Nanohole Arrays 
Further characterization of NHAs was allowed by absorption measurements. 
Alterations in the physical parameters of the nanohole array such as hole size, periodicity, 
thickness and type of metal shift resonances to different spectral locations.38 
Characterization of absorption wavelengths was therefore important to determine optimal 
wavelength(s) for SERS acquisition. Fig. 3.6 displays the absorption spectra of fabricated 
nanohole arrays for square and circularly shaped nanoholes of 0.4, 0.6, 0.8 and 1 μm 
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diameter. Spectra acquired for square wells indicate two resonances in the spectral ranges 
between 620 - 630 cm-1 and 790 – 890 cm-1. Resonances associated with the circular 
nanowells are seemingly less pronounced compared to the square nanowells. Two 
resonances are depicted at 630 - 650 cm-1 and 820 - 850 cm-1 for circular nanowells.  
 
Figure 3.6 – Absorption for horizontally polarized light through (A) square and (B) 
circular nanowells of varying size. 
To ensure the fabricated platforms were SERS active and to additionally 
characterize the representative location of strongest SERS enhancement of the nanowells, 
the surface of the NHA was functionalized for 24 hours in a 1 mM ethanolic solution of 
4-mercaptophenyl boronic acid (4-MPBA). 4-MPBA is a well characterized Raman 
reporter known to form a self-assembled monolayer with gold, through a strong sulfur-
metal bond. It additionally has applications in biosensing.39, 40 Fig. 3.6 displays Raman 
maps for a 0.9 μm circle and 0.9 μm square integrated over the 1074 cm-1 peak 
correlating to the B-OH stretch41 (integration range 1055 – 1100 cm-1). Maps indicate the 
50 
 
strongest enhancement lies in the central cavities of the nanoholes, a promising finding 
for sensing nanoscale materials in these confined regions.  
Representative SERS spectra of 4-MPBA maps are displayed in Fig. 3.7 (C, F). 
SERS-active areas show a strong 4-MPBA signal in central regions of the nanohole array, 
as depicted by spots 1 and 3, whereas areas with a lower SERS enhancement (spots 2 and 
4) show a negligible 4-MPBA signal. Optimal areas of sensing biological materials such 
as EVs would therefore lie in the central cavities of the NHAs.  
 
Figure 3.7 - Mapping of 4-MPBA on a nanohole array surface with f. (A) SEM 
image of 0.9 μm diameter circular nanohole; (B) SERS map of corresponding 
nanohole; (C) SERS spectra of pixels indicated in (B); (D) SEM image of 0.9 μm 
diameter square nanohole; (E) SERS map of corresponding nanohole; (F) SERS 
spectra of pixels 3 and 4 selected in (E). 
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As displayed in Figure 3.7, the SERS enhancement is localized within the central 
cavity of the circular or square nanowells. Due to the beam diameter and step size, we 
observe an overall enhancement over the entire surface of the nanohole cavities, whereas 
no distinguishable SERS response is observed on the nanofilm area (areas 2 and 4). Due 
to the spot-size of the objective (~ 1 micron), we are not able to achieve sufficient spatial 
resolution to map the edges of structures with higher resolution. Since no signal is 
observed from the bare gold substrate, the SERS-active regions are located at the outer 
edges of the nanostructures. 
3.3.4 Trapping Capabilities of Nanohole Arrays 
Trapping of nanomaterials (polystyrene spheres) within nanowells was 
characterized with non-plasmonic nanohole arrays fabricated with a positive resist. To 
trap polystyrene spheres in nanohole arrays, either 1.0 μm fluorescent polystyrene 
spheres or 0.2 μm non-fluorescent polystyrene spheres were drop casted onto circular and 
square nanoholes and allowed to settle for 30 minutes. The non-trapped polystyrene 
spheres were removed by application of an absorbent wipe in the corner of the droplet 
containing the polystyrene solution. This allowed for semi-controlled positioning of 
polystyrene, as cohesive forces resulted in confinement of PS spheres to the edges of the 
nanowells, as seen in Fig. 3.8. 
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Figure 3.8 - Polystyrene spheres trapped within PMMA nanohole arrays. (A) 
Nanohole array of 0.3 μm circles with 0.2 μm polystyrene beads (B) nanohole array 
of 0.4 μm squares with 0.2 μm polystyrene beads (C) 1.0 μm fluorescent polystyrene 
beads trapped in 1 μm circular wells. (D) 1.0 μm fluorescent polystyrene beads 
trapped in 0.9 μm square wells. 
In cases where nanowells were larger than the diameter of polystyrene spheres, 
more than one sphere could become trapped within an individual well, as seen in Fig. 3.8 
B). This is an undesirable finding for vibrational spectral acquisition due to the inability 
to isolate overlapping spectral peaks. However, when the size of the well has similar 
dimension than of the sphere, trapping was noted as more precise (Figure 3.8 A). 
Therefore, when possible, characterization of the size range of the trapped materials is 
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helpful. In the case of polystyrene, the aspect ratio and exact dimensions of the beads are 
known allowing for semi-precise control over the dimensions of wells to best allow for 
successful, non-aggregated trapping.  
The location of trapping of polystyrene spheres is a point of great interest. The 
direction of placement of the absorbent paper in the final step of the trapping protocol 
indicates the direction of trapping of polystyrene spheres, as the spheres are pulled in the 
direction of the capillary force. Spatial control when trapping materials smaller than the 
size of the wells is highly desired for spectroscopic analyses, as control over the location 
of materials may allow for automation of optical measurements since each nanomaterial 
may be referenced by a set of spatial (x,y) coordinates. 
The ability to steer trapped objects to a desired location within nanowells also 
highlights another important benefit of using electron beam lithography to fabricate 
plasmonic materials versus nanosphere lithography. The use of a resist, matched with 
control over the acceleration energy of electrons used to fabricate EBL patterns allows 
for control of depth of wells for trapping. In contrast, nanosphere lithography does not 
allow for controlled spatial positioning in the same manner as EBL, as the large quantity 
of defects and inability to fabricate deeper wells via a resist makes it difficult to trap 
objects reproducibly in controlled locations.  
To further analyze the trapping abilities of nanohole arrays, the same 
methodology as described for trapping of PS microspheres within the non-plasmonic 
NHAs was used with a plasmonic nanohole array fabricated with a negative resist. Once 
polystyrene spheres settled into nanowell cavities, it was possible to probe the SERS 
54 
 
spectra from each individual PS sphere from both above and below/through the nanohole 
array. Probing of SERS spectra above the nanohole array was successful, however 
sensing of PS spheres from below the NHA was of specific interest to confirm that PS 
microspheres were in-fact sitting within individual nanowell cavities. This experiment is 
shown in Figure 3.9. 
 
Figure 3.9 - Sensing of polystyrene spheres through a nanohole array. The sample 
was mounted face-up, facing away from the laser beam source. (A) Areas of interest 
for SERS spectral acquisition. Area 1 highlights a trapped polystyrene sphere 1 μm 
in diameter trapped within a nanowell, whereas area 2 corresponds to a background 
area with no trapped material. Corresponding spectra to (A) are displayed in (B), 
where area 1 displays a peak characteristic of polystyrene and area 2 lacks this 
spectral peak. 
Figure 3.9 B) displays a SERS spectrum obtained from a nanohole array with PS 
trapped in nanowells, facing away from the excitation laser. The peak located at 1000  
cm-1 corresponds to the aromatic breathing mode of the benzene ring and was chosen as a 
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reference peak due to its strong intensity.42 Sensing of materials through the nanohole 
array in confined nanowells was indicative of successful capturing of materials within 
desired areas. This finding is also promising for extending use of this nanodevice to a 
broader set of applications such as trapping of extracellular vesicles, proteins, nucleic 
acids, or growth factors. Incorporation of this nanodevice into point-of-care technologies 
is also promising based on these findings.  
3.4 Conclusions 
In this chapter, two methods are introduced to fabricate plasmonic nanostructured 
substrates for surface-enhanced Raman spectroscopy. Nanosphere lithography was 
successfully performed and characterized with absorption measurements, revealing 
structures with well-defined LSPR positions. Electron beam lithography was also 
completed to allow for better control with positioning of nanostructures. Two separate 
protocols of EBL were successfully demonstrated, one on a positive resist for trapping of 
nanoscale materials, and one on a negative resist for acquisition of SERS spectra. The hot 
spots of nanohole arrays were mapped with a well-known Raman reporter (4-MPBA), 
which successfully demonstrated that hotspots lie within central cavities of wells, 
highlighting ideal sensing areas for materials.  Sensing was further tested with 
polystyrene spheres. Trapping of nanoscale polystyrene spheres displayed controlled 
positioning of materials within desired welled areas, which may allow for future 
automation of spectral acquisitions to well-defined sets of spatial coordinates. The SERS 
spectrum of a trapped polystyrene sphere was also successfully acquired from below a 
nanowell and referenced to the background, indicating successful localization of material 
within confined areas. 
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Chapter 4  
4 Surface-Enhanced Raman Spectroscopy of 
Extracellular Vesicles 
4.1 Introduction 
As cells grow and divide, extracellular vesicles are actively released. The 
umbrella term extracellular vesicle (EV) encompasses three main subgroups of vesicles 
that are classified by their size: (i) exosomes, (ii) microvesicles, and (iii) apoptotic 
bodies.1 The different classifications of vesicles originate from distinct regions of cells 
and through different cellular processes. Depending on the origin of the EV, the 
biochemical composition of the membrane and internal cargoes may vary. As EVs are 
formed, biomolecules including DNA, mRNA, lipids, and proteins from the parent cell 
are introduced into the cytosolic core.2 Examining both the external and internal 
components of the extracellular vesicle may be used as a means of determining the source 
and modes of action of specific EVs within the body. 
The study of EVs has intensified in recent years due to their potential diagnostic 
and prognostic applications. EVs have been found to play important roles in disease 
progression and have been related to neurodegenerative diseases such Alzheimer’s3, 4 and 
Parkinson’s diseases5, 6, as well as prostate1, 7-9, lung10 and breast cancers11, 12. One 
diagnostic approach to examine biomarkers incorporated in EVs is by western blotting13, 
14. This approach is particularly useful for comparing EVs originating from healthy and 
diseased cells, as different biomarkers may become overexpressed or expressed to a 
greater degree in diseased states. For example, the expressions of exosome biomarkers 
present in breast cancer patients are significantly higher when compared to healthy 
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controls or benign breast tumor patients. There is potential to use these biomarkers for 
detection and diagnosis of breast cancer.13   
Isolation of EVs from human biofluids, such as tears,15 urine,16 blood,7, 11, 16 and 
cerebrospinal fluid3 present many challenges for researchers. Their isolation from other 
biological components such as free-floating proteins and cell debris highlights the 
fundamental importance of being able to capture and probe the EVs at low quantities. It is 
necessary to note that although there is a correlation amongst a parent cell and the EVs it 
releases, the presence and distribution of biomarkers may vary depending on the type, 
mode, and location of the vesicle released. Therefore, a given parent cell releases EVs 
with varying biomarker expressions.17 As such, techniques capable of identifying the 
variability and presence of biomarkers at the single EV level in short periods of time are 
of great interest.  
Recently, several novel methods have been reported indicating noteworthy 
progress towards detection and characterization of individual EVs. For example, Hu et al. 
incorporated surface plasmon resonance (SPR) sensing into antibody-specific 
microarrays to detect and sense individual exosomes.18 Microarrays were functionalized 
with antibodies complementary to membrane surface proteins of exosomes, allowing for 
immobilization of individual of exosomes upon interaction. Changes in the local 
refractive index at the surface of the nanodevice signaled successful binding events for 
enumeration. This method was successful at counting individual exosomes, however it 
required labelling with antibodies. As a result, any exosomes lacking the antigen on their 
membrane surface, or expressing a low quantity of antigens on their surface may not been 
eliminated from final counts. Alternatively, nanoparticle tracking analysis (NTA) has 
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been presented in recent years as a technique to quantify individual exosomes in real-
time. Song et al. utilized NTA to quantify exosomes collected from human sweat 
samples.19 NTA employs a laser beam to measure and single particle size and 
concentration of particles in solution. This technique was successful at quantifying 
exosome counts, however was not capable of providing molecular or proteomic 
information without incorporation of additional techniques such as western blotting. In 
addition to SPR sensing and NTA, Raman spectroscopy and surface-enhanced Raman 
spectroscopy (SERS) have emerged as promising techniques for quantification of 
individual EVs.  
Raman spectroscopy is a well-established technique for characterizing biological 
materials. It provides molecular information in a non-destructive and label-free manner, 
making it a highly useful technique for studying biological materials in their natural 
environments. It has been applied to a variety of biological studies including cancer 
studies,20,21 neurodegenerative diseases,22,23 immunology24,25 and microbiology26,27. It has 
previously been utilized as a tool to study extracellular vesicles by laser tweezers Raman 
spectroscopy (LTRS), which utilizes a tightly focused laser beam to trap particles at the 
lasers focal point. Smith et al. used LTRS to trap and discern the similarities and 
differences amongst individual exosomes isolated from eight different cell lines.28 Since 
LTRS is a label-free technique, no prior knowledge of surface proteins was required. 
They reported spectral variability in the relative expressions of phospholipids to 
cholesterol amongst exosomes released when comparing cancerous to non-cancerous cell 
lines. They were also successful in trapping and probing molecular information from 
individual exosome. Braeckmans et al. attempted to characterize the diversity of 
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individual exosomes isolated from different cell lines based on a nanoparticle approach.29 
Deposition of a gold nanoparticle shell allowed for SERS sensing of exosomes. The study 
was successful at identifying and characterizing individual exosomes, however their 
isolation protocol introduced intense SERS peaks from background reagents, which 
limited the information gained by the study.  
Detection of individual extracellular vesicles from human biofluids or cell culture 
supernatant is often a challenge due to lack in characterization methodology and lack of 
standardization in isolation protocol. Of the many methods proposed for isolation, some 
of the most common methods are differential/gradient ultracentrifugation and low-speed 
centrifugation by commercial isolation reagent kits.30 Ultracentrifugation techniques are 
known to be time-consuming and tedious, but have yielded good purification results. 
Commercial isolation reagent kits lack specificity in isolation. These kits act by 
precipitating vesicles with polyethylene glycol or similar polymers, which ultimately 
results in contamination of isolates with the polymeric agents.17, 29 This largely limits 
vibrational spectroscopy results, as peaks from isolation reagent kits may predominate 
over the natural/intrinsic spectral response of the biological materials.   
In this chapter, a new approach to detect the chemical content and presence of 
bulk EV samples with surface-enhanced Raman spectroscopy (SERS) is presented. We 
additionally extend this work to detection and trapping of individual EVs using nanohole 
arrays (NHAs). EVs from a pancreatic mesenchymal stromal cell line were isolated to 
analyze the similarities and differences amongst EVs. Protocols used for EV isolation 
aimed to minimize spectral contamination from backgrounds to ultimately extract 
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molecular information directly from EVs by use of centrifugation and filtration 
methodologies.  
4.2 Experimental 
4.2.1 Cell Culturing of Pancreatic Mesenchymal Stem Cell Line 
Ricordi-chamber isolated human islets were obtained through the Integrated Islet 
Distribution Program (IIDP) funded by the National Institute of Diabetes and Digestive 
and Kidney Diseases (NIDDK). 200 islet equivalents were cultured in RPMI 1640 + 10% 
FBS (Thermo Fisher) for up to 7 days. Between days 5-7, cells with a mesenchymal stem 
cell (MSC) phenotype1 were trypsinized and segregated from adherent islet preps using a 
40𝜇m cell strainer (Corning). Single cell suspensions were subsequently seeded on tissue 
culture plastic at 4,000 cells/cm2 in Amniomax-C100TM (Gibco Life Technologies) 
supplemented with AmniomaxTM E100 Supplement (Gibco Life Technologies) to 
support MSC colony formation. Primary human pancreatic cells were deemed to be 
tissue-specific MSC (Panc-MSC), according guidelines established by the International 
Society of Cellular Therapies. Panc-MSC were passaged when flasks reached 80-90% 
confluency and utilized for experimentation at passage 4. Cells were enumerated using 
Countess II FL (Life Technologies) prior to subsequent experimentation.  
4.2.2 Isolation of EVs from Mesenchymal Cell Line 
Conditioned media (CM) was generated by culturing Panc-MSC to ~80% 
confluency, rinsed twice with pre-warmed PBS, and cultured for 24 hours in serum-free 
Aminomax C100. To remove contaminating dead cells or debris, MSC-CM was 
centrifuged at 600g for 7 minutes. Cell-free MSC-CM was centrifuged in Amicon Ultra-
15 100kDa centrifuge filter units (Millipore) for 20 minutes at 2800g. This concentrated 
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fraction is enriched with extracellular vesicles (EV+ MSC-CM) and depleted proteins 
<100kDa. EV+ MSC-CM was rinsed twice with deionized water to remove any residual 
phenol red from prepared samples.  
4.2.3 Cell Culturing of Human Prostate Cancer Cell Line (PC3) 
Human prostate cancer cell line, PC3 cells were obtained from ATCC (CRL 
1435TM, Manassas, VA, USA) and maintained in Roswell Park Memorial Institute 
(RPMI)-1640 medium (Wisent, Saint-Jean-Baptiste, QC) and supplemented with 10% 
fetal bovine serum (FBS, Wisent, Saint-Jean-Baptiste, QC). The cultures were maintained 
and grown to a confluency of ~80% in an incubator at 37 °C, 5% CO2, 100% humidity for 
three to four days. For fluorescent studies, human PC3 cells were labelled with zeta-green 
through a lentiviral transduction according to a protocol similar to Swaison et al.31 
To grow additional cells, cells were split by rinsing with phosphate-buffered 
saline (PBS) (Wisent, Saint-Jean-Baptiste, QC) followed by treatment with trypsin-
EDTA (Wisent, Saint-Jean-Baptiste, QC) and incubation for 2-5 minutes in 37°C, 5% 
CO2, 100% humidity for detachment. Twice the quantity of RPMI, supplemented with 
10% FBS was added to the trypsinized cells for neutralization, after which cells 
suspended in trypsin and culture media were centrifuged at 250 g for two minutes to 
pellet cells. Supernatant was collected for exosome extraction, and the cellular pellet was 
re-suspended in cell culture media in new flasks with RPMI for further cell growth and 
EV isolation. Flasks were incubated under the same conditions as mentioned above until 
cells reached a confluency of ~ 80%. 
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4.2.4 Isolation of EVs from Human Prostate Cancer Cell Line (PC3) 
Following cell culturing and media isolation as described in section 2.1, collected 
media containing released EVs was centrifuged at 250 g for 5 minutes. Pellets of 
remaining cells were discarded and supernatant was poured into an Amicon EMD 100 
kDa Millipore filter (Millipore Sigma), centrifuged at 3200 g for 20 - 30 minutes, while 
shaking every five minutes to reduce the concentration gradient between the filter and 
filtrate. Timing of centrifugation varied between 20 – 30 minutes depending on the 
volume and concentration of EVs being sorted through the Millipore filter. EVs were 
collected and placed into Eppendorf tubes, and stored at – 20 °C for up to 1 month, or at 
– 80 °C for long-term storage.  
4.2.5 EV Preservation for SEM Imaging 
For scanning electron micrograph (SEM) purposes, preservation of EVs to retain 
their natural spherical shape without bursting upon drying was carried out according to 
protocol by Wu et al.32 EVs isolated from media were fixed in 4 % paraformaldehyde 
(PFA) (v/v) for 10 minutes. After which, the process of preservation was completed by 
adding 20% dimethyl siloxane (DMSO) (v/v) to the sample. The sample was aliquoted 
into vials and stored at – 20 0C for up to one month prior to use. 
4.2.6 Substrate Fabrication and Trapping of EVs within Nanohole 
Arrays 
Fabrication of NSL substrates and metallic nanohole arrays followed the protocols 
outlined in 3.2.1 and 3.2.2.2. To prepare nano-array samples, concentrated EV samples 
were diluted with milli-Q water. The dilution factor varied based on the concentration of 
EVs in the sample, and dilutions were either 1:2, 1:3, 1:4, 1:5 or 1:10 depending on the 
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sample. 20 μL of EV-water solution was drop-casted onto the nano-arrays fabricated by 
EBL (see section 2.2) and allowed to dry for 20 – 30 minutes to trap EV within nano-
wells. Removal of EV-water solution from the array was performed using the cohesive 
properties allowed by an absorbent paper (Kimberly-Clark Inc.). The edge of the 
absorbent paper was placed onto the corner of the solution droplet, allowing for removal 
of solution via capillary action.  
4.2.7 Spectroscopic Characterization 
Raman spectra were obtained with a Horiba Jobin-Yvon Raman spectrometer 
equipped with a 600 grooves/mm grating and a 623.8 nm excitation source. An optical 
objective of 100 × (N.A 0.9) was used to collect backscattered light. The pinhole of the 
spectrometer was opened to 200 μm. Acquisition time was 20 seconds per spectra, and 
power at the sample was 0.5 mW. For SERS mapping experiments of 4-MPBA, an 
acquisition time of 5 seconds was used. For SERS measurements with extracellular 
vesicles, laser power was 0.5 mW at the sample and exposure time varied between 20 – 
100 s. 
4.3 Results and Discussion 
4.3.1 Characteristics of EVs 
The human prostate cancer cell line, PC3 was used for characterization of EVs. 
This cell line was chosen due to its ability to grow, proliferate and produce EVs rapidly. 
In addition, this cell line is straight-forward to work with, requiring standard cell-
handling protocols and is a cell line of interest for this research project due to its 
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cancerous nature. Optical, fluorescence and scanning electron micrograph (SEM) images 
were obtained of growing cell cultures, as indicated in Figure 4.1. 
 
Figure 4.1 – Images of a healthy PC3 cell line used for EV isolation and 
characterization (A) Optical image of a growing cell culture, with its corresponding 
fluorescence image (B); (C) SEM of a healthy PC3 cell, displaying sharp edges and 
protrusions. 
Optical and fluorescence images were obtained to determine confluency and health of 
growing cell cultures. Live-cell images were obtained with an EVOS FLoid Cell Imaging 
Station (Thermo Fisher Scientific). For concentrated extraction of EVs in cell culture 
media, the confluency of cells was measured to be > 80%. Therefore, images 4.1 (A) and 
(B) display confluencies too low for EV isolation but show healthy cell cultures for 
eventual EV isolation. Cells depicted in these images would require a few additional days 
for growth before EVs extraction takes place. A SEM image is included in Fig. 4.1 (C) to 
highlight the characteristic morphology of healthy PC3 cells. Healthy PC3 cells are 
polygonal in shape, have sharp boundaries between adjacent cells and have 
characteristically long ‘arm-like’ projections radiating from their sides.33   
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Figure 4.2 – Images of isolated EVs. (A) Fluorescent image of isolated EVs (B) 
preserved EVs on a silicon wafer. 
Isolation of EVs was validated by fluorescence microscopy and SEM. The 
fluorescence image in Figure 4.2 A) displays a large quantity of isolated vesicles varying 
in size. There also exists a variability in fluorescence, highlighting a fundamentally 
important aspect of cellular release of EVs. When parent cells are stained with 
fluorescent dye, the dye becomes integrated into different areas of the cell in variable 
amounts. Depending on the location and method of release of each EV, it is expected that 
EVs may display differences in their fluorescence intensities based on their mode and 
location of release.34  
To visualize the spherical nature of EVs, protocol by Wu et al.32 was followed to 
preserve EVs, which involved immersing the EV solution in 4% PFA (v/v) followed by 
treatment with 20% DMSO (v/v). Preserved EVs show their expected, characteristic 
spherical shape (Figure 4.2 B). EVs outlined in this image display a dramatic size 
difference and are therefore thought to be a larger EV (apoptotic body) attached to a 
smaller EV (microvesicle). Both vesicles would be released through different cellular 
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mechanisms, and likely adhered to one another during fixation.  It is important to note 
that although preservation of EVs maintains structural integrity, the PFA and DMSO 
used for preservation may lead to spectral changes to the natural spectroscopy of EVs, 
making this method ideal for imaging and trapping of EVs, but non-ideal for spectral 
acquisition.  
4.3.2 SERS of EVs (PC3) 
Following successful isolation of EVs, it was desirable to probe their spectral 
characteristics by SERS. Nanosphere lithography substrates were fabricated to obtain 
preliminary SERS spectra to determine the biochemical makeup of bulk sets of EVs. 
Vesicles were drop casted onto NSL substrates and allowed to dry overnight. The sample 
was then mounted in an inverted configuration, facing the 633 nm He-Ne laser.  
 
Figure 4.3 (a) NSL substrate containing dried EVs, of which a (b) SERS spectra was 
obtained of an EV (red) and of the background (blue). 
Figure 4.3 outlines setup of the spectroscopic experiments. First, the laser was 
focused on the EV (highlighted in red). Following acquisition of this spectra over a 20-
second period, the laser was moved to the background area beside the dried EV for 
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comparison (highlighted in blue). Representative spectra are shown in Figure 4.3 (B). 
The sharp, well defined peaks obtained from the EV were compared to those presented in 
the literature and displayed many commonalities with EVs previously probed with 
Raman and SERS (Table 3). Commonalities with previous spectroscopic experiments on 
EVs included peaks correlating to lipids, nucleic acids and proteins such as the ν(C-C) 
peak at 1139 cm-1, the C–O ribose nucleic acid stretch at 1109 cm-1 and the δ(CH2/CH3) 
protein or lipid stretch located at 1444 cm-1. Differences also existed when compared to 
the literature. These variations are expected to exist not only amongst EVs released from 
different cell lines, but also within a given cohort of EVs released from the same cell 
line.35, 41, 42 
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Table 3 - SERS peak assignment for PC3 EV 
Raman Shift 
(cm-1) 
Presumed Origin/Assignment of Peak Reference 
1039 ν(C-C) (lipid) 22, 44 
1110 ν(C-O) (nucleic acid) 22, 44 
1142 ν(C-C) (lipid) 43 
1330 ω(CH3CH2) (nucleic acid) 22, 44 
1412 δ(CH2) (lipid) 22, 43 
1444 δ(CH2/CH3) (protein, lipid) 22, 35, 44 
1569 ω(CH2/ CH3) tryptophan (nucleic acid) 22, 44 
1667 v(C=O) Amide I (protein, cholesteryl ester) 35, 43, 45 
2976 v(CH3) (lipid, fatty acid, cholesterol ester) 43 
To confirm consistency in peaks acquired from EVs of the PC3 cell line, 
additional SERS spectra were acquired on NSL substrates. A high degree of similarity 
was noted, as seen in Figure 4.4. Note that the green trace corresponds to the spectra 
previously displayed in Figure 4.3 (B). Peaks outlined in Figure 4.4 showed a high degree 
of similarity to those previously outlined in Table 3. Additional peaks arose for lipids and 
carbohydrates between 2900 – 3400 cm-1, noting C-H and unsaturated =CH stretches.43  
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Figure 4.4 – SERS spectra obtained from PC3 derived EVs on a NSL substrate 
prepared by the O-ring method. 
To confirm that vibrational peaks arose from EVs rather than background 
contamination from cell culture reagents, background spectra were acquired for all agents 
used during cell culture and EV isolation. These background spectra include (1) RPMI 
media; (2) RMPI media supplemented with 10% fetal bovine serum; (3) fetal bovine 
serum; (4) PBS buffer and (5) Trypsin-EDTA. Concentrated solutions of each 
background solution were drop-casted onto individual glass cover slips and probed by 
Raman spectroscopy. Representative spectra for these backgrounds, acquired over 10 
second acquisition times are displayed in Figure 4.5. 
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Figure 4.5 – Representative background spectra from PC3 cell line. 
Background spectra did not display any sharp spectroscopic peaks and therefore 
do not compare to those previously acquired for EVs. SERS peaks obtained from EVs on 
NSL substrates may be assigned directly to the EVs, rather than from spectral 
contamination by background agents.  
To gain a better understanding of the variability that exists amongst vesicles released 
from different cell lines, a mesenchymal stem cell line was cultured for EV isolation. 
Study of EVs released from mesenchymal stem cells have applications in regenerative 
medicine,40 and in studies for organ injury repair.41 A NSL-based experiment was 
prepared in the same manner as previously outlined PC3 isolated EVs. Spectra were 
acquired for 100 s, and three representative spectra are shown in Figure 4.6.  
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Figure 4.6 – SERS of EVs from a mesenchymal stem cell line on a NSL platform. 
These spectra display similarities and differences when compared to one another. 
These similarities and differences are further discussed in 4.3.3.  
4.3.3 Trapping and Spectral Probing of EVs in NHAs 
To visualize trapping of EVs within nanowells, a diluted solution was prepared by 
mixing EVs with milli-Q water in a 1:3 v/v ratio. The solution was drop-casted onto the 
nanohole array substrate, and an absorbent wipe was placed on the nanohole array to 
remove excess and non-trapped EVs. Trapping of EVs displayed similar trapping patterns 
compared polystyrene particles, previously characterized in 3.3.4.  
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Figure 4.7 – SEM images of EVs trapped within (A) a square nanowell of 0.8 μm 
diameter; (B) a 1 μm diameter circular nanowell (C) a 0.5 μm square nanowell; (D) 
optical image of a 1 μm diameter square nanowells. 
Figure 4.7 displays SEM and optical images obtained for trapping of EVs within 
nanowells. Within the 0.8 μm diameter square nanowell, two EVs visibly became trapped 
in opposite corners. The spectral readout of this nanowell would therefore likely 
correspond to both EVs, therefore delineation of peaks arising from one EV would not be 
possible. To this point, if a 100 × objective with a N.A of 0.9 was utilized for 
spectroscopic measurements, the laser focal diameter would measure roughly 1 μm in 
diameter, probing information from the entire nanowell. However, in cases where one EV 
becomes trapped within a given well, the spectral information of one EV would be 
probed. Trapping of one EV per nanowell is the desired result of this experiment, 
76 
 
however it is important to recognize that probed spectra may be resultant from the 
spectral overlap of more than EV due to the beam diameter. To allow for more precise 
trapping of only one EV per well, possible experimentation could be to functionalize 
nanowells with antibodies for capture based on membrane antigens/proteins.42 Dilution of 
antibodies and functionalization could allow for more precise control over capture. Since 
this work seeks to minimize spectral contamination from background reagents, capture by 
antibodies was not explored.  
In Figure 4.7 C), an EV larger than the diameter of the nanowell became trapped, 
and eventually ruptured. This trend is promising for capture and probing of larger sized 
EVs. An optical image is also provided in Figure 4.7 D) to highlight the trapping 
efficiency of EVs within a given array of wells. The bright yellow colours correspond to 
dried cell culture media or background agents used for isolation of EVs, whereas the 
darker regions within welled areas are thought to correspond to trapped vesicles. 
Trapping efficiency in this case is quite high for the 1 μm diameter square nanowells, 
although variability has been noted to exist when comparing samples. 
Following trapping and sorting of EVs within metallic nanohole arrays, SERS 
spectra were acquired. SERS spectra of the mesenchymal cell line obtained within the 
NHA correlated strongly to those previously obtained on the NSL substrate. Background 
spectra of cell culture media is shown in Figure 4.8, and three representative spectra are 
shown in Figure 4.9. 
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Figure 4.8 - Background Raman spectra of cell culture media for mesenchymal stem 
cell line.  
Background spectra display no defined Raman peaks that would interfere with the 
intrinsic SERS response of EVs. Acquisition times ranged between 10 – 100 s for the 
spectra displayed.  
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Figure 4.9 - SERS of EVs trapped in a nanohole array within (1) 0.7 μm diameter 
circular well; (2) 0.9 μm diameter square well; (3) 0.8 μm diameter square. Spectra 
are shifted for clarity. 
The Raman spectra selected are representative of the data set acquired, and were 
selected due to their similar intensities, thereby eliminating any need for data processing 
software for enhancement signal to noise ratios. The spectra displayed common 
vibrational peaks. The intensities of predominant peaks varied, which we hypothesize is 
due to the intrinsic differences amongst the EV population, even when released from the 
same cell line. The peaks arising at 669, 1320 and 1602 cm-1 come from nucleic acids and 
amino acids.29, 37, 43 The peak located at 1386 cm-1 present in spectra 1 and 2 corresponds 
to a δCH3 vibration, most likely associated with the membrane of the vesicles. Depending 
on location of entrapment within the nanowell, it is possible that this membrane vibration 
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was not detectable for the vesicle probed in spectra 3. The strong peaks between 1490 
and 1497 cm-1, present in all three spectra correlate to δ C-N/ ν (N-H), likely from an 
amide II stretch in proteins.37 The peaks present between 1566 and 1576 cm-1 correlate to 
the nucleic acids or proteins such as tryptophan, guanine and phenylalanine, 
respectively.29, 37 These results provide information regarding variability at the single 
vesicle level, information that may be used to further clarify the roles of EV subtypes in 
reference to their chemical makeup and ultimate biological function(s). 
Table 4 - SERS peak assignment for mesenchymal EVs 
Raman Shift 
(cm-1) 
Presumed Origin/Assignment of Peak Reference 
669 ν(C-S) cytosine (nucleic acid) 37 
700 ν(C-S) methionine (protein)/ ν(C-C) cholesterol 
ester (lipid) 
38, 37 
1320 ω(CH3CH2) (nucleic acid) 29, 37 
1344 δ(CH) deformations (lipid or nucleic acid) 44 
1379 δCH3 (lipid) 29 
1386 δCH3 (lipid) 29, 37 
1494 δC-N/ ν(N-H) (protein) 37 
1566 ν(C-C) tryptophan (nucleic acid) 29, 44 
1576 δ(C=C) phenylalanine (protein)/ guanine (nucleic 
acid) 
44, 29 
1602 ν(C=C) phenylalanine (protein) 43 
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The intensity differences amongst spectra in Fig. 4.9 are believed to be resultant 
from a variety of factors. These factors include the presence and non-presence of 
biomolecules such as proteins and nucleic acids as well as the distribution of these 
biomolecules. Additionally, upon entrapment and bursting of extracellular vesicles in air 
conditions, some contents may burst on the edges or sides of the nanowells.38 Bursting of 
the EVs on the edges of plasmonic nanowells is expected to yield a greater enhancement 
compared to the glass area in the center of the wells. We would therefore expect to see a 
variation in response due to these factors.  
The height differences between peaks shared amongst the spectra are 
hypothesized to be indicative of the varying cargoes present on the surface and within the 
EVs. For example, the peak present in spectra 1 and 2 at 669 cm-1 is indicative of a 
different quantity of nucleic acids present in each vesicle. Previous literature has reported 
that nucleic acids may be present on the external surface or within the central cavities of 
EVs.45 The increased strength of this peak in spectra 2 compared to spectra 3 may be 
indicative of the presence of DNA/RNA on the surface of the EV in spectra 2. This likely 
would yield a more intense signal, as the DNA would be located closer to the metallic 
nanohole array generating the greatest electromagnetic enhancement by SERS. However, 
it is also possible that these nucleic acids may have been released upon drying and 
bursting of the EVs within the nanowells.38 These findings suggest that for one given 
class of EV, there exists a diversity in the biochemical composition and distribution of 
biological cargoes. 
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4.3.4 Extracellular Vesicle Differentiation and Similarity  
When the spectral characteristics of the PC3-derived EVs are compared to the 
mesenchymal stem cell produced EVs, similarities are noted for nucleic acid, protein and 
lipid stretches. Figure 4.9 highlights commonalities and differences amongst these 
vesicles. 
 
Figure 4.10 - Comparison of SERS spectra of EVs probed by NSL from 
mesenchymal and prostate (PC3) cell lines. 
A high degree of similarity is noted when comparing SERS spectra from EVs of 
varying origin. Analysis of common peaks arising from individual EVs derived from 
different cell lines suggests conserved biological functions. Since membrane components 
are composed of lipids a high degree of overlap for peaks arising from membranous 
lipids is expected. In addition, since EVs are released through the cytosolic center of 
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cells, proteins and nucleic acids packaged into their core are expected to be universally 
present. Peaks common amongst both EV lines are assigned in Table 5.  
Smith et al. noted similar findings, suggesting conserved biological function 
amongst EVs released from seven different cell lines.28 Using statistical analysis 
(principle component analysis), cholesterol content, surface protein expression and the 
relative expression of phospholipids to cholesterol were highly conserved. Statistical 
analysis by principle component analysis would be of great interest for discerning the 
most common peaks shared amongst the two EV lines studied in this work. PCA could 
also be used to generate a library or barcoding system to definitively differentiate and 
compare EVs, which has previously been suggested in the literature.46, 47 Barcoding of 
EVs by SERS could provide potential benefits in disease diagnosis, as understanding the 
variability shared amongst one EV line and between different EV lines may potentially 
allow for definitive detection of biomarkers present in diseases and cancers. To perform 
statistical analysis, large sets of data would be required. Multiplexing by on-chip sensing 
would assist greatly in acquisition of large data sets. Automation of spectroscopic 
measurements of fabricated NHAs by defining each nanowell to a set of spatial 
coordinates may potentially allow for this type of analysis in future work.  
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Table 5 - Peak assignment for peaks shared amongst PC3 and mesenchymal EVs 
Raman Shift 
(cm-1) 
Presumed Origin/Assignment of Peak Reference 
695 - 705 ν(C-S) (methionine, protein) / ν(C-C) Cholesterol 
ester (lipid) 
38, 37 
895 – 900 ρ(CH2) (protein) 29 
1110 - 1115 ν(C - O) (ribose, nucleic acid) 29 
1310 – 1330 ν(C- N) (protein)/ τ(CH3CH2) (lipid) 29 
1570 - 1575 ν(C-C) Tryptophan (nucleic acid) 29, 44 
 
4.4 Conclusion 
Throughout this chapter, isolation of EVs was successfully verified by 
fluorescence and scanning electron microscopy. Fixation of the membranes of EVs 
revealed intact, spherical membranes and displayed a variation in size verifying 
successful isolation of exosomes, microvesicles and apoptotic bodies. Trapping of EVs 
was subsequently characterized by fabrication of nanohole arrays, which revealed capture 
of EVs in corner regions of square and circular nanowells. Nanohole arrays with 
plasmonic capabilities were also fabricated for compatibility with surface-enhanced 
Raman spectroscopy.  
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Sorting and probing by SERS of individual extracellular vesicles was allowed by 
fabrication of metallic nanohole arrays. SERS results presented good agreement to those 
presented in the literature, showing presence of expected lipid, protein and nucleic acid 
peaks. Raman spectra of background reagents further concluded that peaks were from 
intrinsic EV signatures. This approach therefore eliminates the need for background 
subtraction from isolation reagent kits, as direct isolation of EVs occurred by 
combination of filtration and centrifugation. 
Amongst EVs isolated from the same cell line, similarities and differences were 
noted, suggesting some EVs contain higher quantities of biomolecules compared to 
others. Comparison of EVs isolated from two different cell cultures also showed 
similarities and differences. Similarities included nucleic acid content as well as lipid and 
protein content, suggesting conserved biological functions. We therefore demonstrated 
that nanowell-based SERS substrates may be used to capture and probe nanomaterials for 
molecular-level characterization. This nanodevice holds high potential in point-of-care 
diagnostics for cancer or disease detection.   
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Chapter 5  
5 Conclusions and Outlook  
5.1 Conclusions 
Nanofabrication techniques such as nanosphere lithography and electron beam 
lithography are promising methods of fabricating metallic nanostructures in a 
reproducible manner. Although the applications of metallic nanostructures vary widely 
across scientific subdisciplines, they have been used extensively for spectroscopic 
analyses due to their plasmonic capabilities.1-5  Incorporation of nanostructures into chip-
based sensors holds extreme potential in development of point-of-care technologies for 
disease detection and diagnosis. Recently, chip-based sensors involving nanofabrication 
techniques have developed devices with extreme sensitivities to study a variety of 
biological, physical and chemical phenomena.6-8  
Throughout this thesis, nanosphere lithography and electron beam lithography 
were presented as lithographic techniques to probe molecular information from biological 
vesicles.  Chapter 1 highlighted current work within the fields of nanofabrication, 
extracellular vesicles and point-of-care sensor development. Chapter 2 presented the 
main biological, chemical and physical information underlying extracellular vesicles and 
nanofabrication. Specific interest was also placed on direct and indirect sensing of 
biomaterials for disease diagnosis and detection.   
Fabrication and characterization of nanostructures and substrates were 
characterized throughout Chapter 3, wherein the LSPR positions of NSL and EBL 
structures were obtained by absorption measurements to allow for matching of LSPR 
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positions with the incident light source. The O-ring method of NSL was offered as a 
means of fabricating reproducible and semi-controlled regions of nanoprisms.9 EBL was 
further performed on a positive-tone resist to assess the trapping capabilities of nanowell 
cavities with polystyrene spheres of a known aspect ratio. These samples were 
characterized by SEM, fluorescence and optical imaging. Results indicated successful 
fabrication of nanostructures by NSL and EBL, and successful confinement of PS spheres 
within nanowell areas in nanohole arrays was noted. 
The ability to efficiency trap and probe EVs in metallic NHAs was presented in 
Chapter 4. Electron beam lithography was performed on a negative-tone resist, allowing 
for fabrication of glass nanowells surrounded in metal. Functionalization of the NHA 
with a well-known Raman reporter highlighted ideal sensing areas for SERS. Spatial 
resolution was limited during mapping due to the 100 × (0.9 N.A.) objective, which 
confined the laser beam to a 1 μm x 1 μm2 area on the NHA substrate. However, mapping 
was successful in proving hot-spots lied within central glass nanowell cavities. This was 
tested by detection of polystyrene spheres from below a metallic nanohole array. SERS 
acquisition revealed expected spectra for polystyrene, demonstrating successful 
confinement of nanomaterials to desired sensing areas.   
Successful trapping of PS nanospheres and subsequent SERS acquisition lead to 
probing of spectral signatures of EVs in Chapter 4. The structural characteristics of EVs 
were first characterized by fluorescence and SEM, revealing isolated vesicles with intact 
lipid membranes. NSL substrates were subsequently used to characterize the average 
SERS response of a bulk EV sample (unsorted). The components of bulk EV samples 
revealed contents with nucleic acids, lipids and proteins and displayed high similarity to 
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the EV samples characterized previously in the literature.1, 10, 11  Metallic NHAs were then 
used to sort and trap individual EVs and for acquisition of SERS spectra. Trapping within 
nanowells was successful. SEM imaging revealed the ability of the NHA to capture more 
than one EV per nanowell, which may be circumvented future work by use of antibodies 
specific to EV membranes.  
Probing of SERS spectra from EVs trapped within wells of a metallic NHA 
revealed spectral characteristics similar to those acquired on NSL substrates. There 
existed a diversity amongst EVs isolated from the same cell line, suggesting different 
roles and release mechanisms for individual vesicles. Intensity differences amongst the 
EV population from an individual cell line signaled increases in the quantity of specific 
biomaterial components. The SERS spectra of EVs released from two cell lines, a 
prostate cancer cell line and a mesenchymal stem cell line were also compared. The 
presence of nucleic acids, as well as lipid and protein contents suggested conserved 
biological functions, a finding previously reported in the literature.10 Conserved 
biological functions such as lipid membranes for protection and encapsulation of 
materials are essential for formation of EVs and were therefore expected to display 
themselves in SERS spectra from both EV lines.  
This thesis demonstrated successful fabrication of a nanohole-array based sensor 
capable of probing molecular information from nanoscale biological materials. This 
nanodevice holds high potential in point-of-care diagnostics for cancer or disease 
detection.   
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5.2 Outlook 
Throughout this thesis, a nanoscale device was fabricated for trapping, sorting and 
probing of nanoscale biological materials known as extracellular vesicles. The 
nanodevice allowed for molecular-level characterization of biological vesicles isolated 
from cultured cell lines by SERS. Future work may seek to combine nanohole arrays with 
microfluidic technologies. If microfluidic channels are fabricated to sort and isolate 
vesicles from other biological debris, flow through of EVs onto nanohole arrays could 
allow for direct and rapid detection of EVs from human liquid biopsies. This would 
extend the device to a point-of-care screening tool, whereby clinicians could better assess 
and diagnose patients with less-invasive screening tools. 
In line with incorporation of NHAs into a microfluidic device, previous literature 
by Wang et al. highlights a method of isolating EVs from biological samples by 
incorporation of microfluidics and nanofabrication.12 This group fabricated a nanodevice 
containing ciliated micropillar structured forming a nanowire-on-micropillar trap for 
selective capture of exosome-like vesicles (40 – 100 nm in diameter). Flow of EVs 
through the device selectively trapped exosomes within nanowires, while proteins and 
cell debris flowed through the device for removal (Figure 5.1). Exosomes were recovered 
by flooding the device with phosphate-buffered saline (PBS), a buffer solution commonly 
used during cell culture/EV isolation. In the future, a device incorporating nanowire-on-
micropillar traps for initial isolation of EVs from complex biological samples, followed 
with recovery of EVs in PBS and subsequent flow through of EVs onto a nanohole array 
could allow for SERS-based detection of EVs from complex biological samples.  
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Figure 5.1 - Exosomes trapped within “nanowire-on-micropillar” structures and 
subsequently separated from cellular debris and proteins. Inlay shows (a) 
Nanowires; (b) Micropillars; (c) “Nanowire-on-micropillar” structures. Reproduced 
with permission.12 
 In this thesis, electron beam lithography (EBL) was presented as a means of 
fabricating metallic nanohole arrays in a reproducible manner. Although EBL presents 
many advantages over other lithographic techniques due to its high resolution and 
reproducibility, fabrication of metallic nanohole arrays requires significant amounts of 
time and requires advanced nanofabrication skills. Other methods of fabrication may be 
explored in the future to minimize these limitations. In recent years, stencil lithography 
has emerged as a great method for fabrication of nanohole arrays.13 Stencil lithography is 
a resistless, scalable and high-throughput technique allowing for fabrication of 
nanostructures over large surface-areas with a reusable mask. Nanostencil lithography 
has also been presented on non-conventional lithographic substrates such as flexible 
polymers14, 15 and PDMS-based microfluidic devices.13 Fabrication costs can largely be 
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minimized by reuse of nanostencil masks. In addition, the mask may be fabricated to 
cover the entire surface area of the substrate and requires less advanced training due to 
non-use of resists and an electron beam source. 
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